Clinical Trial: A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112
Study Status: Completed
Recruit Status: Completed
Condition: Atopic Dermatitis
Study Type: Interventional
Official Title: Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112
Brief Summary:
To evaluate safety, tolerability and pharmacokinetics of NCP 112 after single and multiple applications on the skin of healthy male volunteers.
Read more